Filing Details

Accession Number:
0001683168-22-000673
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-03 20:15:22
Reporting Period:
2022-02-01
Accepted Time:
2022-02-03 20:15:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
704562 Avid Bioservices Inc. CDMO Pharmaceutical Preparations (2834) 953698422
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1723288 B Richard Hancock 2642 Michelle Drive, Suite 200
Tustin CA 92780
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2022-02-01 3,378 $4.67 38,578 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2022-02-01 3,378 $18.80 35,200 No 4 S Direct
Common Stock, $0.001 Par Value Acquisiton 2022-02-01 1,622 $4.53 36,822 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2022-02-01 1,622 $18.82 35,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-02-01 3,378 $0.00 3,378 $4.67
Common Stock Stock Option (right to buy) Disposition 2022-02-01 1,622 $0.00 1,622 $4.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
240,509 2027-11-27 No 4 M Direct
238,887 2026-05-07 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2021.
  2. Represents a weighted average sales price per share. These shares were sold at prices ranging from $18.21 to $19.21. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. Represents a weighted average sales price per share. These shares were sold at prices ranging from $18.47 to $19.22. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. Stock option granted to the reporting person on November 27, 2017 vested monthly over a three (3) period and was fully vested as of November 27, 2020.
  5. Stock option granted to the reporting person on May 7, 2019, vests in four (4) equal annual installments beginning May 7, 2020 and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.